References
- Oriental medicine dictionary editing committee. Supplemental Oriental medicine dictionary, Seoul, Jeongdam, 1998:1354.
- Kim JS. Standard Galenicalpharmacy, Seoul, Jinmyung publishing company, 1975:353.
- Ouh ER. Bonchoujongshin, Seoul, Hanglimseswon, 1972:120.
- Mun G et al. East & West Combine Treatment of Cancer II, Iksan, Wonkwang Univ, 1999:741-93.
- Chung BS et al. Illustrated Herb dictionary, Seoul Youngrimsa, 1990:775-7.
- Gae WB. Pharmacology & application of Anticancer Herb, Harbin, Hukrunggang Science technology publishing company, 1999:1200, 1268-9.
- Oriental Herb dictionary editing committee. Supplemental Oriental Herb dictionary(8), Seoul, Jeongdam, 1997:3711-4.
- Shin KG. Shinssi Hebal Medicine, Seoul, Sumunsa, 1982:160-1.
- Lee SJ. Bonchougangmok, Beijing, Human Health publishing company, 1988:1987-91.
- Shin MG. Clinical Galenicalpharmacy, Seoul, Youngrimsa, 1988:591-592.
- Chai YM. New Pharmacology & application of Chinese Herb, Beijing, Hwaha publishing company, 1999:521.
- Rae JK et al. Chinese Clinical Galenicalpharmacy(ha), Beijing, Human Health publishing company, 1998:1856-8.
- Pathology Society of Korea. Pathology, Seoul, Komunsa, 1990:179-86.
- Bang YJ. Practical Chinese internalmedicine, Shanghai, Shanghai science technology publishing company, 1986:12-6, 621-35.
- Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.Cancer Res, 1993:53:3979-85.
- Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR. The p53 network. J. Biol. Chem. 1998:273:1-4. https://doi.org/10.1074/jbc.273.1.1
- Korean Health Organization. : Korean herb standard book, Seoul, 1984:111.
- Gangsou New medicine academy. Chinese Herb dictionary I(ha), Shanghai, Shanghai science technology publishing company, 1979:2587-9.
- Tang W, Eisenbrand G. Chinese drugs of plant origin.Springer-Verlag, New York, 1992:51-7.
- Martin SJ et al. Proteolysis of fodrin (nonerythroid spectrin) during apoptosis. J. Biol. Chem, 1995:270:6425-8.
- Alnemri ES et al. Human ICE/CED-3 protease nomenclature. Cell, 1996:87:171. https://doi.org/10.1016/S0092-8674(00)81334-3
- Hwang SG et al. Proteolysis of beta-catenin in apoptotic Jurkat cells. Journal of Life Science, 2000:10:57-63.
- Bicknell GR, Snowden RT, Cohen GM. Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukemic cell line. U937. J. Cell Sci, 1994:107:2483-9.
- Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclindependent kinase inhibitors (CKIs). Oncogene, 1995:11:211-19.
- Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 nheterodimerizes in vivo with a conserved homolog, Bax, thataccelerates programmed cell death. Cell, 1993:74:609-619. https://doi.org/10.1016/0092-8674(93)90509-O
- Driks PB, Rutka JT. Current concepts in neurooncology: thecell cycle. Neurosurgery, 1997:40: 1000-13. https://doi.org/10.1097/00006123-199705000-00025
- Serrano M, Hannon GJ, Beach D. A new regulatory motif incell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 1993:366:704-7. https://doi.org/10.1038/366704a0
- Baek HR. Byunjeongshidhi outline, Unnam, Human publishing company, 1984:502.
- Ashall F, Bramwell ME, Harris H. A new marker for humancancer cells. Lancet, 1982:2:1-6.
- Suffness M, Douros J. Current status of the NCI plant and animal product program. J. Nat. Prod, 1982:45:1-14. https://doi.org/10.1021/np50019a001
- Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol, 1991:139:271-9.
- Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification ofprogrammed cell death in situ via specific labeling of nuclear DNAfragmentation. J. Cell Bio, 1992:119:493-501. https://doi.org/10.1083/jcb.119.3.493
- Wang JY, Knudsen ES, Welch PJ. The retinoblastoma tumor suppressor protein. Adv. Cancer Res, 1994:64:25-85.
- Ruddon RW. Chemical carcinogenesis. In principles of drug action (3rd.), Churchill Livingstone, 1999:735.
- Son GW. Chinese Treatment of Leukemia, Hongkong, Haebong publishing company, 1990:112-3.
- Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell Biol, 1995:15:2612-24. https://doi.org/10.1128/MCB.15.5.2612
- An WG, Hwang SG, Trepel JB, Blagosklonny MV. Protease inhibitor -induced apoptosis: accumulation wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers ofproteasome inhibition. Leukemia, 2000:14:1276-83. https://doi.org/10.1038/sj.leu.2401812
- School of Medicine Seoul national univ. Oncology, Seoul national univ publishing part, 1992:1-3, 78-90, 137-43, 225-34.
- Moran P. Cellular effects of cancer chemotherapy administration. J. Intraven. Nurs, 2000:23:44-51.